Gonadectomy and dehydroepiandrosterone (DHEA) do not modulate disease progression in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 3, 2012, Pages 311-314

  Hayes Punzo, Antonio ^a   Mulcrone, Patrick ^a   Meyer, Michael ^a   Mchugh, Jacalyn ^b   Svendsen, Clive N ^b   Suzuki, Masatoshi ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Amyotrophic lateral sclerosis (ALS); Dehydroepiandrosterone (DHEA); Gonadectomy; Sexual dimorphism; SOD1 G93A rats

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; PRASTERONE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GONADECTOMY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; STEROID BLOOD LEVEL; SURVIVAL;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; ORCHIECTOMY; OVARIECTOMY; RATS; SEX FACTORS; SUPEROXIDE DISMUTASE; SURVIVAL ANALYSIS;

EID: 84860357566     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2012.654393     Document Type: Article

References (14)

1. McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7:557-70.
2. Veldink JH, Bar PR, Joosten EA, Otten M, Wokke JH, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13:737-43. (Pubitemid 37258345)
3. Choi CI, Lee YD, Gwag BJ, Cho SI, Kim SS, Suh-Kim H. Effects of estrogen on lifespan and motor functions in female hSOD1-G93A transgenic mice. J Neurol Sci. 2008; 268:40-7. (Pubitemid 351389466)
4. Suzuki M, Tork C, Shelley B, McHugh J, Wallace K, Klein SM, et al. Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph Lateral Scler. 2007;8:20-5. (Pubitemid 46322935)
5. Groeneveld GJ, van Muiswinkel FL, Sturkenboom JM, Wokke JH, Bar PR, van den Berg LH. Ovariectomy and 17beta-estradiol modulate disease progression of a mouse model of ALS. Brain Res. 2004;1021:128-31. (Pubitemid 39158664)
6. Bastianetto S, Ramassamy C, Poirier J, Quirion R. Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Molecular Brain Research. 1999;66:35-41. (Pubitemid 29148331)
7. Suzuki M, Wright LS, Marwah P, Lardy HA, Svendsen CN. Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc Natl Acad Sci USA. 2004;101:3202-7. (Pubitemid 38327758)
8. Kimonides VG, Khatibi NH, Svendsen CN, Sofroniew MV, Herbert J. Dehydroepiandrosterone (DHEA) and DHEAsulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc Natl Acad Sci U S A. 1998;95:1852 - 7. (Pubitemid 28103483)
9. Fiore C, Inman DM, Hirose S, Noble LJ, Igarashi T, Compagnone NA. Treatment with the neurosteroid dehydroepiandrosterone promotes recovery of motor behavior after moderate contusive spinal cord injury in the mouse. J Neurosci Res. 2004;75:391-400. (Pubitemid 38173475)
10. Celec P, Starka L. Dehydroepiandrosterone: Is the fountain of youth drying out? Physiol Res. 2003;52:397-407. (Pubitemid 37039903)
11. Suzuki M, Bannai M, Matsumuro M, Furuhata Y, Ikemura R, Kuranaga E, et al. Suppression of copulatory behavior by intracerebroventricular infusion of antisense oligodeoxynucleotide of granulin in neonatal male rats. Physiol Behav. 2000;68:707-13. (Pubitemid 30182471)
12. Klein SM, Behrstock S, McHugh J, Hoffmann K, Wallace K, Suzuki M, et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum Gene Ther. 2005;16:509-21. (Pubitemid 40647148)
13. Suzuki M, Klein S, Wetzel EA, Meyer M, McHugh J, Tork C, et al. Acute glial activation by stab injuries does not lead to overt damage or motor neuron degeneration in the G93A mutant SOD1 rat model of amyotrophic lateral sclerosis. Exp Neurol. 2010;221:346-52.
14. Militello A, Vitello G, Lunetta C, Toscano A, Maiorana G, Piccoli T, et al. The serum level of free testosterone is reduced in amyotrophic lateral sclerosis. J Neurol Sci. 2002; 195:67-70. (Pubitemid 34175101)